CN105859716A - Method for synthesizing 5-6 parallel-ring structure in camptothecin compounds - Google Patents
Method for synthesizing 5-6 parallel-ring structure in camptothecin compounds Download PDFInfo
- Publication number
- CN105859716A CN105859716A CN201610296979.0A CN201610296979A CN105859716A CN 105859716 A CN105859716 A CN 105859716A CN 201610296979 A CN201610296979 A CN 201610296979A CN 105859716 A CN105859716 A CN 105859716A
- Authority
- CN
- China
- Prior art keywords
- alkyl
- hydrogen
- acid
- ring
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XVSGZWIOXFNEFD-UHFFFAOYSA-N CCCc1c(CN(C2=CC3=C4COCC3CC)C4=O)c2nc2c1cccc2 Chemical compound CCCc1c(CN(C2=CC3=C4COCC3CC)C4=O)c2nc2c1cccc2 XVSGZWIOXFNEFD-UHFFFAOYSA-N 0.000 description 1
- 0 CC[C@](C(C=C(*1CC2=CC=CC)C2=*C=CC)=C(CO2)C1=O)(C2=O)OC Chemical compound CC[C@](C(C=C(*1CC2=CC=CC)C2=*C=CC)=C(CO2)C1=O)(C2=O)OC 0.000 description 1
- MUKPQKKHPVLHNK-UHFFFAOYSA-N O=C1N(CC(C2)C3=Nc4c2cccc4)C3=CC=C1 Chemical compound O=C1N(CC(C2)C3=Nc4c2cccc4)C3=CC=C1 MUKPQKKHPVLHNK-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种合成喜树碱类化合物中5‑6并环结构的方法,所述方法是使具有式II结构的共轭烯炔酯在溶剂中发生分子内的串联环化反应,从而制得式I所示的5‑6并环结构,具体反应式为:式中:R1和R2分别独立选自氢、烷基、环烷基、芳基或杂环基;或者,R1和R2一起形成饱和或不饱和的碳环或杂环;R3和R4分别独立选自氢、烷基、环烷基、芳基或杂环基;或者,R3和R4一起形成饱和或不饱和的碳环或杂环;R选自C1~C4烷基;P为氨基保护基。本发明所述方法具有操作简单,安全环保,生产成本低,收率高,适合规模化生产等优点,对促进该类化合物在医药领域的广泛应用具有重要价值。The invention discloses a method for synthesizing the 5-6 asymmetric ring structure in camptothecin compounds, the method is to make the conjugated enynyl ester with the structure of formula II undergo intramolecular series cyclization reaction in a solvent, thereby The 5-6 parallel ring structure shown in formula I is obtained, and the specific reaction formula is: In the formula: R 1 and R 2 are independently selected from hydrogen, alkyl, cycloalkyl, aryl or heterocyclic group; or, R 1 and R 2 together form a saturated or unsaturated carbocyclic or heterocyclic ring; R 3 and R 4 are independently selected from hydrogen, alkyl, cycloalkyl, aryl or heterocyclyl; or, R 3 and R 4 together form a saturated or unsaturated carbocyclic or heterocyclic ring; R is selected from C 1 to C 4 alkyl; P is an amino protecting group. The method of the invention has the advantages of simple operation, safety and environmental protection, low production cost, high yield, suitable for large-scale production, etc., and has great value in promoting the wide application of this type of compound in the field of medicine.
Description
技术领域technical field
本发明是涉及一种合成喜树碱类化合物中5-6并环结构的方法,属于有机合成技术领域。The invention relates to a method for synthesizing a 5-6 asymmetric ring structure in camptothecin compounds, belonging to the technical field of organic synthesis.
背景技术Background technique
喜树碱类化合物中含有二氢吡咯-2-羰基吡啶的5-6并环结构该类化合物具有良好的抗癌活性,例如:喜树碱(Camptothecin)是美国科学家Wall和Wani等于1966年从喜树的树皮中分离得到的一种生物碱,目前已经成为临床上最著名的植物类抗癌药之一;除此以外,人们还从喜树中分离出大量的喜树碱类天然产物,如:10-hydroxycamptochecin、22-hydroxyacuminate等;基于喜树碱天然药物的化学研究,目前还发展出许多具有良好抗癌活性的喜树碱衍生物,如:化合物Topotecan及Irinotecan被美国药物食品管理局(FDA)批准上市,上述化合物的化学结构式分别如下所示:The 5-6 ring structure of dihydropyrrole-2-carbonylpyridine in camptothecin compounds This kind of compound has good anticancer activity, for example: camptothecin (Camptothecin) is a kind of alkaloid that American scientist Wall and Wani equal to 1966 and obtain from the bark of Camptotheca isolated, has become the most famous clinically at present. One of the plant anticancer drugs; in addition, people have also isolated a large number of camptothecin natural products from camptothecin, such as: 10-hydroxycamptochecin, 22-hydroxyacuminate, etc.; based on the chemical research of camptothecin natural medicines, At present, many camptothecin derivatives with good anticancer activity have been developed, such as: the compounds Topotecan and Irinotecan have been approved by the U.S. Food and Drug Administration (FDA), and the chemical structural formulas of the above compounds are as follows:
目前,关于喜树碱类化合物中含有的二氢吡咯-2-羰基吡啶的5-6并环结构的合成方法主要有以下几种:At present, the synthetic method of the 5-6 ring structure of the dihydropyrrole-2-carbonylpyridine contained in the camptothecin compound mainly contains the following types:
1)Stork小组于1971年公开了消旋Camptothecin的合成路线(Stork G.,Schultz A.G.J.Am.Chem.Soc.1971,36,4074.):1) The Stork group disclosed the synthetic route of racemic Camptothecin in 1971 (Stork G., Schultz A.G.J.Am.Chem.Soc.1971,36,4074.):
此路线共需16步,总产率约为20%,反应步骤冗长,操作繁琐,生产成本高,因此该合成路线不适合工业化生产。This route needs 16 steps in total, and the total yield is about 20%. The reaction steps are lengthy, the operation is cumbersome, and the production cost is high. Therefore, this synthetic route is not suitable for industrial production.
2)Comins小组于1992年公开了Camptothecin的不对称全合成路线(D.L.Comins,M.F.Baevsky,H.Hong,J.Am.Chem.Soc.1992,114,10971.):2) The Comins group disclosed the asymmetric total synthesis route of Camptothecin in 1992 (D.L.Comins, M.F.Baevsky, H.Hong, J.Am.Chem.Soc.1992,114,10971.):
此路线共需10步,总产率只有12%,还需要使用当量的手性辅基,生产成本高,因此该合成路线也不适合工业化生产。This route requires a total of 10 steps, and the total yield is only 12%. It also needs to use equivalent chiral prosthetic groups, and the production cost is high, so this synthetic route is not suitable for industrial production.
3)Curran小组于1995年公开了Camptothecin及其多种衍生物的合成路线(D.P.Curran,S.KO,H.Josien,Angew.Chem.Int.Ed.1995,34,2683.):3) The Curran group disclosed the synthetic route of Camptothecin and its various derivatives in 1995 (D.P.Curran, S.KO, H.Josien, Angew.Chem.Int.Ed.1995, 34, 2683.):
此路线运用自由基反应,经过12步合成目标产物,总产率仅3%,生产成本高,并且还使用到有毒的锡试剂,环境污染大,生产安全性较差,因此该合成路线也不适合工业化生产。This route uses free radical reaction, after 12 steps to synthesize the target product, the total yield is only 3%, the production cost is high, and toxic tin reagent is also used, the environmental pollution is large, and the production safety is relatively poor, so this synthetic route is not Suitable for industrial production.
4)姚祝军小组于2007年公开了Camptothecin的不对称全合成路线(H.Zhou,G.Liu,Z.Yao,Org.Lett.2007,9,2003.):4) Yao Zhujun’s group disclosed the asymmetric total synthesis route of Camptothecin in 2007 (H.Zhou, G.Liu, Z.Yao, Org.Lett.2007,9,2003.):
此路线共需14步反应,反应步骤冗长,操作繁琐,总产率约为15%,并且还使用到昂贵的金属试剂,生产成本高,因此该合成路线仍不适合工业化生产。This route requires a total of 14 steps of reaction, the reaction steps are lengthy, the operation is cumbersome, the total yield is about 15%, and expensive metal reagents are used, and the production cost is high, so this synthetic route is still not suitable for industrial production.
综上所述,虽然含有二氢吡咯-2-羰基吡啶的5-6并环结构的喜树碱类化合物具有良好的生物活性,但是这些化合物的合成方法目前还存在路线繁琐、操作复杂、成本较高、收率较低等缺陷,因此阻碍了这些化合物在医药领域的开发应用。In summary, although camptothecin compounds with a 5-6 ring structure containing dihydropyrrole-2-carbonylpyridine have good biological activity, the synthesis methods of these compounds still have cumbersome routes, complicated operations, and high cost. Higher, lower yields and other defects have hindered the development and application of these compounds in the field of medicine.
发明内容Contents of the invention
针对现有技术存在的上述问题,本发明的目的是提供一种操作简单、安全环保、收率较高的合成喜树碱类化合物中5-6并环结构的方法,以促进该类化合物在医药领域的广泛应用。In view of the above-mentioned problems existing in the prior art, the purpose of the present invention is to provide a method for synthesizing the 5-6 ring structure in camptothecin compounds with simple operation, safety and environmental protection, and higher yield, so as to promote the synthesis of such compounds in Wide application in the field of medicine.
为实现上述发明目的,本发明采用的技术方案如下:For realizing above-mentioned purpose of the invention, the technical scheme that the present invention adopts is as follows:
一种合成喜树碱类化合物中5-6并环结构的方法,是使具有式II结构的共轭烯炔酯在溶剂中发生分子内的串联环化反应,从而制得式I所示的5-6并环结构,具体反应式如下所示:A method for synthesizing the 5-6 parallel ring structure in camptothecin compounds is to make the conjugated enynyl ester with the structure of formula II undergo an intramolecular series cyclization reaction in a solvent, thereby preparing the compound shown in formula I 5-6 ring structure, the specific reaction formula is as follows:
其中:in:
R1和R2分别独立选自氢、烷基、环烷基、芳基或杂环基;或者,R1和R2一起形成饱和或不饱和的碳环(包括芳环、稠环)或杂环(包括烷基杂环、芳杂环、稠杂环);R 1 and R 2 are independently selected from hydrogen, alkyl, cycloalkyl, aryl or heterocyclic group; or, R 1 and R 2 together form a saturated or unsaturated carbocycle (including aromatic ring, condensed ring) or Heterocycles (including alkyl heterocycles, aromatic heterocycles, and condensed heterocycles);
R3和R4分别独立选自氢、烷基、环烷基、芳基或杂环基;或者,R3和R4一起形成饱和或不饱和的碳环(包括芳环、稠环)或杂环(包括烷基杂环、芳杂环、稠杂环);R 3 and R 4 are independently selected from hydrogen, alkyl, cycloalkyl, aryl or heterocyclic group; or, R 3 and R 4 together form a saturated or unsaturated carbocycle (including aromatic ring, condensed ring) or Heterocycles (including alkyl heterocycles, aromatic heterocycles, and condensed heterocycles);
R选自C1~C4烷基(例如:甲基、乙基、丙基、丁基,优选甲基);R is selected from C 1 -C 4 alkyl groups (for example: methyl, ethyl, propyl, butyl, preferably methyl);
P为氨基保护基(例如:叔丁氧羰基、苄氧羰基、苄基、对甲氧基苄基、芴甲氧羰基、三苯甲基或乙酰基,优选叔丁氧羰基)。P is an amino protecting group (for example: tert-butoxycarbonyl, benzyloxycarbonyl, benzyl, p-methoxybenzyl, fluorenylmethoxycarbonyl, trityl or acetyl, preferably tert-butoxycarbonyl).
作为优选方案,式I化合物具有如下结构通式:As a preferred version, the compound of formula I has the following structural formula:
其中: in:
环A具有式A-1、A-2或A-3所示结构:Ring A has the structure shown in formula A-1, A-2 or A-3:
其中:Ra1、Ra4、Ra5各自独立的选自氢、烷基、芳基、氟或烷氧基;Ra2、Ra3各自独立的选自氢、烷基、芳基、氟或烷氧基;或者,Ra1和Ra2、Ra2和Ra3、Ra3和Ra4、Ra1和Ra5一起形成碳环或杂环; Wherein: Ra 1 , Ra 4 , Ra 5 are each independently selected from hydrogen, alkyl, aryl, fluorine or alkoxy; Ra 2 , Ra 3 are each independently selected from hydrogen, alkyl, aryl, fluorine or alkane Oxygen; or, Ra 1 and Ra 2 , Ra 2 and Ra 3 , Ra 3 and Ra 4 , Ra 1 and Ra 5 together form a carbocyclic or heterocyclic ring;
环B具有式B所示结构:Ring B has the structure shown in Formula B:
其中:Rb1、Rb2、Rx、Rm各自独立的选自氢、烷基、芳基、氟或烷氧基;虚线表示任选的双键,X为C、N、O或S,当1位与2位之间为双键时,X只能为C或N;当1位与2位之间为双键且X为N时,Rx不存在; Wherein: Rb 1 , Rb 2 , Rx, Rm are each independently selected from hydrogen, alkyl, aryl, fluorine or alkoxy; the dotted line represents an optional double bond, X is C, N, O or S, when 1 When there is a double bond between bit and 2, X can only be C or N; when there is a double bond between 1 and 2 and X is N, Rx does not exist;
m为0、1、2或3,当m为0时,Rm不存在。m is 0, 1, 2 or 3, and when m is 0, Rm does not exist.
作为进一步优选方案,环A中:Ra1、Ra4、Ra5均选自氢;Ra2、Ra3均选自氢、氟、烷基或烷氧基;或者,Ra2和Ra3一起形成氧杂环(例如:1,3-二氧戊环);环B中:Rb1、Rb2、Rx、Rm各自独立的选自氢、烷基、芳基、氟或烷氧基;虚线表示任选的双键,X为C、N或O,当1位与2位之间为双键时,X为C或N;当1位与2位之间为双键且X为N时,Rx不存在;m为0或1,当m为0时,Rm不存在。As a further preferred solution, in ring A: Ra 1 , Ra 4 , and Ra 5 are all selected from hydrogen; Ra 2 and Ra 3 are all selected from hydrogen, fluorine, alkyl or alkoxy; or, Ra 2 and Ra 3 are formed together Oxyheterocycles (e.g. 1,3-dioxolane ); in ring B: Rb 1 , Rb 2 , Rx, Rm are each independently selected from hydrogen, alkyl, aryl, fluorine or alkoxy; the dotted line represents an optional double bond, X is C, N or O, When there is a double bond between 1 and 2, X is C or N; when there is a double bond between 1 and 2 and X is N, Rx does not exist; m is 0 or 1, when m is 0 , Rm does not exist.
作为优选方案,使具有式II结构的共轭烯炔酯溶于溶剂中,先在酸性条件、0±5℃下反应1~5小时,然后浓缩除去酸,再使得到的产物重新溶于溶剂中,在碱性条件、0~60℃下进一步反应,制得式I结构的化合物。As a preferred solution, the conjugated enynyl ester having the structure of formula II is dissolved in a solvent, first reacted under acidic conditions at 0±5°C for 1 to 5 hours, then concentrated to remove the acid, and then the obtained product is re-dissolved in the solvent , further reacting under alkaline conditions at 0-60°C to obtain a compound of the formula I structure.
作为进一步优选方案,反应中所用的酸选自盐酸、硫酸、甲磺酸、三氟乙酸、对甲苯磺酸、樟脑磺酸中的至少一种。As a further preferred solution, the acid used in the reaction is at least one selected from hydrochloric acid, sulfuric acid, methanesulfonic acid, trifluoroacetic acid, p-toluenesulfonic acid, and camphorsulfonic acid.
作为进一步优选方案,反应中所用的碱选自二异丙基氨基锂、六甲基二硅基氨基锂、六甲基二硅基氨基钠、六甲基二硅基氨基钾、碳酸锂、碳酸钠、碳酸钾、碳酸铯、氢氧化锂、氢氧化钠、氢氧化钾、磷酸钾、叔丁醇钠、叔丁醇钾、三乙胺、二异丙基乙基胺、1,8-二氮杂二环十一碳-7-烯中的至少一种。As a further preferred version, the base used in the reaction is selected from lithium diisopropylamide, lithium hexamethyldisilazide, sodium hexamethyldisilazide, potassium hexamethyldisilamide, lithium carbonate, carbonic acid Sodium, potassium carbonate, cesium carbonate, lithium hydroxide, sodium hydroxide, potassium hydroxide, potassium phosphate, sodium tert-butoxide, potassium tert-butoxide, triethylamine, diisopropylethylamine, 1,8-di At least one of azabicycloundec-7-enes.
作为进一步优选方案,反应中所用的溶剂选自甲苯、四氢呋喃、乙二醇二甲醚、二氯甲烷、1,4-二氧六环、甲醇、叔丁醇、N,N-二甲基甲酰胺、二甲亚砜、乙腈中的至少一种。As a further preferred version, the solvent used in the reaction is selected from toluene, tetrahydrofuran, ethylene glycol dimethyl ether, dichloromethane, 1,4-dioxane, methanol, tert-butanol, N,N-dimethylformaldehyde At least one of amides, dimethyl sulfoxide, and acetonitrile.
作为进一步优选方案,碱性条件下的反应温度为0~60℃。As a further preferred solution, the reaction temperature under alkaline conditions is 0-60°C.
与现有技术相比,本发明具有如下显著性有益效果:Compared with the prior art, the present invention has the following significant beneficial effects:
本发明通过共轭烯炔酯(式II所示化合物)自身分子内的串联环化反应,一步制得喜树碱类化合物中5-6并环结构,整个路线操作简单,各种试剂均简单易得,可商业购买,成本低廉,且不涉及有毒有害危险品试剂,安全环保,同时反应条件温和,无需高温高压操作,体系稳定,重复性好,生产成本低,收率高(90%左右),适合规模化生产,从而可促进该类化合物在医药领域的广泛应用。In the present invention, the 5-6 parallel ring structure in the camptothecin compound is prepared in one step through the tandem cyclization reaction in the molecule of the conjugated enynyl ester (compound represented by formula II), the whole route is simple to operate, and various reagents are simple Easy to get, can be purchased commercially, low cost, and does not involve toxic and harmful reagents, safe and environmentally friendly, while the reaction conditions are mild, no high temperature and high pressure operation is required, the system is stable, the repeatability is good, the production cost is low, and the yield is high (about 90%) ), suitable for large-scale production, thereby promoting the wide application of this type of compound in the field of medicine.
具体实施方式detailed description
下面结合具体实施例对本发明技术方案做进一步详细、完整地说明。The technical solutions of the present invention will be further described in detail and completely below in conjunction with specific embodiments.
实施例1:的制备Example 1: preparation of
1)取水杨酸甲酯1(1.7mL,13.1mmol)于100mL圆底烧瓶中,加入60mL(0.2M)的二氯甲烷,于0℃下滴加5.5mL三乙胺、3.3mL三氟甲磺酸酐,然后于0℃下反应2小时,加水,用乙酸乙酯萃取,合并萃取液,用饱和氯化钠洗涤,无水硫酸钠干燥,过滤,旋干溶剂,柱层析(3%乙酸乙酯/石油醚),得淡黄色液体,即:化合物2(3.3g,产率为89%),Rf=0.56(20%乙酸乙酯-石油醚)。1) Take methyl salicylate 1 (1.7mL, 13.1mmol) in a 100mL round bottom flask, add 60mL (0.2M) of dichloromethane, add 5.5mL triethylamine and 3.3mL trifluoromethane dropwise at 0°C Sulfonic anhydride, then reacted at 0°C for 2 hours, added water, extracted with ethyl acetate, combined the extracts, washed with saturated sodium chloride, dried over anhydrous sodium sulfate, filtered, spin-dried the solvent, column chromatography (3% acetic acid ethyl ester/petroleum ether) to obtain a light yellow liquid, namely: compound 2 (3.3 g, yield 89%), Rf=0.56 (20% ethyl acetate-petroleum ether).
2)称取可市购的化合物3(20g,105mmol)于1L圆底烧瓶中,加入500mL(0.2M)的四氢呋喃,于0℃下分批加入4.0g硼氢化钠,然后于0℃下反应1小时,加丙酮淬灭反应,加水,用乙酸乙酯萃取,合并萃取液,用饱和氯化钠洗涤,无水硫酸钠干燥,过滤,旋干溶剂;2) Weigh commercially available compound 3 (20g, 105mmol) into a 1L round bottom flask, add 500mL (0.2M) tetrahydrofuran, add 4.0g sodium borohydride in batches at 0°C, and then react at 0°C For 1 hour, add acetone to quench the reaction, add water, extract with ethyl acetate, combine the extracts, wash with saturated sodium chloride, dry over anhydrous sodium sulfate, filter, and spin to dry the solvent;
将所得粗品直接溶于500mL(0.2M)的干燥四氢呋喃,滴加20mL 1,8-二氮杂二环十一碳-7-烯、26.6mL叠氮磷酸二苯酯,在室温下反应4小时,加入1N盐酸淬灭反应,加水,用乙酸乙酯萃取,合并萃取液,依次用饱和碳酸氢钠和饱和氯化钠洗涤,无水硫酸钠干燥,过滤,旋干溶剂;Dissolve the obtained crude product directly in 500 mL (0.2 M) of dry tetrahydrofuran, add dropwise 20 mL of 1,8-diazabicycloundec-7-ene and 26.6 mL of diphenylphosphoryl azide, and react at room temperature for 4 hours , adding 1N hydrochloric acid to quench the reaction, adding water, extracting with ethyl acetate, combining the extracts, washing with saturated sodium bicarbonate and saturated sodium chloride successively, drying with anhydrous sodium sulfate, filtering, and spinning to dry the solvent;
将所得粗品直接溶于500mL(0.2M)的四氢呋喃,于0℃下加入32.4g三苯基膦,在室温下反应16小时,加入124mL氨水,继续在室温下反应3小时,加入500mL氢氧化钠溶液(2.5N),继续室温反应2小时,用乙酸乙酯萃取,合并萃取液,用饱和氯化钠洗涤,无水硫酸钠干燥,过滤,旋干溶剂;Dissolve the obtained crude product directly in 500mL (0.2M) tetrahydrofuran, add 32.4g triphenylphosphine at 0°C, react at room temperature for 16 hours, add 124mL ammonia water, continue to react at room temperature for 3 hours, add 500mL sodium hydroxide Solution (2.5N), continue to react at room temperature for 2 hours, extract with ethyl acetate, combine the extracts, wash with saturated sodium chloride, dry over anhydrous sodium sulfate, filter, and spin to dry the solvent;
将所得粗品直接溶于500mL(0.2M)的二氯甲烷,滴加21mL三乙胺、26mL二碳酸二叔丁酯,于室温下反应2小时,加入饱和氯化铵淬灭反应,加水,用乙酸乙酯萃取,合并萃取液,依次用饱和碳酸氢钠和饱和氯化钠洗涤,无水硫酸钠干燥,过滤,旋干溶剂,柱层析(3%乙酸乙酯/石油醚),得淡黄色液体,即:化合物4(24.2g,四步产率为79%),Rf=0.27(20%乙酸乙酯-石油醚)。The resulting crude product was directly dissolved in 500 mL (0.2 M) of dichloromethane, 21 mL of triethylamine and 26 mL of di-tert-butyl dicarbonate were added dropwise, and reacted at room temperature for 2 hours, then quenched by adding saturated ammonium chloride, adding water, and using Extracted with ethyl acetate, combined extracts, washed with saturated sodium bicarbonate and saturated sodium chloride successively, dried over anhydrous sodium sulfate, filtered, spin-dried the solvent, column chromatography (3% ethyl acetate/petroleum ether), obtained light Yellow liquid, ie: compound 4 (24.2 g, 79% yield over four steps), Rf=0.27 (20% ethyl acetate-petroleum ether).
3)称取化合物4(1.5g,5.1mmol)于50mL圆底烧瓶中,加入180mg二氯二三苯基膦钯、49mg碘化亚铜、25mL(0.2M)除氧的甲苯,在氮气保护下加入2.9mL三乙胺、1.1mL三甲基硅基乙炔,于室温反应12小时,硅藻土过滤,旋干溶剂,柱层析(5-15%乙酸乙酯/石油醚),得淡黄色固体;将所得产品溶于25mL(0.2M)的甲醇,于0℃下加入138mg碳酸钾,于0℃下反应10分钟,加入饱和氯化铵淬灭反应,加水,用乙酸乙酯萃取,合并萃取液,用饱和氯化钠洗涤,无水硫酸钠干燥,过滤,旋干溶剂,柱层析(20-30%乙酸乙酯/石油醚),得淡黄色固体,即:化合物5(1.3g,两步产率为88%),Rf=0.11(20%乙酸乙酯-石油醚)。3) Weigh compound 4 (1.5g, 5.1mmol) in a 50mL round bottom flask, add 180mg dichlorobistriphenylphosphine palladium, 49mg cuprous iodide, 25mL (0.2M) deoxygenated toluene, under nitrogen protection 2.9 mL of triethylamine and 1.1 mL of trimethylsilylacetylene were added, and reacted at room temperature for 12 hours, filtered through diatomaceous earth, spin-dried the solvent, and column chromatography (5-15% ethyl acetate/petroleum ether) gave light Yellow solid; the resulting product was dissolved in 25mL (0.2M) of methanol, 138mg of potassium carbonate was added at 0°C, reacted at 0°C for 10 minutes, quenched by adding saturated ammonium chloride, added water, extracted with ethyl acetate, The extracts were combined, washed with saturated sodium chloride, dried over anhydrous sodium sulfate, filtered, spin-dried, and column chromatography (20-30% ethyl acetate/petroleum ether) to obtain a pale yellow solid, namely: compound 5 (1.3 g, two-step yield 88%), Rf = 0.11 (20% ethyl acetate-petroleum ether).
4)称取化合物2(50mg,0.18mmol)、化合物5(50mg,0.18mmol)于50mL圆底烧瓶中,加入10mg四三苯基膦钯、196mg四丁基碘化铵、2mg碘化亚铜,在氮气保护下加入2mL(0.1M)除氧的三乙胺/乙腈(1/4),于80℃下反应5小时,硅藻土过滤,旋干溶剂,柱层析(10-15%乙酸乙酯/石油醚),得淡黄色固体,即:反应所需的共轭烯炔酯(52mg,产率为70%),Rf=0.41(30%乙酸乙酯-石油醚)。4) Weigh compound 2 (50mg, 0.18mmol) and compound 5 (50mg, 0.18mmol) in a 50mL round bottom flask, add 10mg tetraphenylphosphine palladium, 196mg tetrabutylammonium iodide, 2mg cuprous iodide , add 2mL (0.1M) deoxygenated triethylamine/acetonitrile (1/4) under nitrogen protection, react at 80°C for 5 hours, filter with diatomaceous earth, spin to dry the solvent, column chromatography (10-15% ethyl acetate/petroleum ether) to give a light yellow solid, that is: the conjugated enynyl ester required for the reaction (52 mg, 70% yield), Rf = 0.41 (30% ethyl acetate-petroleum ether).
5)称取制备的共轭烯炔酯(100mg,0.24mmol)于10mL反应管中,加入1.2mL(0.2M)的二氯甲烷,于0℃下滴加0.1mL三氟乙酸,然后于0℃下反应12小时,旋干溶剂,用真空泵抽干,除去多余的三氟乙酸;将所得粗品直接溶于2mL甲醇,加入氢氧化钾(27mg,0.48mmol),于40℃下反应18小时,旋干溶剂,加水,用二氯甲烷萃取,合并萃取液,用饱和氯化钠洗涤,无水硫酸钠干燥,过滤,旋干溶剂,柱层析(40%乙酸乙酯/二氯甲烷),得淡黄色固体,即:(61mg,产率为90%),Rf=0.73(10%甲醇/二氯甲烷)。5) Weigh the prepared conjugated enynyl ester (100mg, 0.24mmol) into a 10mL reaction tube, add 1.2mL (0.2M) of dichloromethane, dropwise add 0.1mL trifluoroacetic acid at 0°C, then react at 0°C for 12 hours, spin the solvent, and use Vacuum pump to remove excess trifluoroacetic acid; directly dissolve the resulting crude product in 2 mL of methanol, add potassium hydroxide (27 mg, 0.48 mmol), react at 40 ° C for 18 hours, spin to dry the solvent, add water, and extract with dichloromethane , combined the extracts, washed with saturated sodium chloride, dried over anhydrous sodium sulfate, filtered, spin-dried the solvent, and column chromatography (40% ethyl acetate/dichloromethane) gave a light yellow solid, namely: (61 mg, 90% yield), Rf = 0.73 (10% methanol/dichloromethane).
经测试:1H NMR(400MHz,CDCl3):δ8.52(d,J=8.0Hz,1H),8.28(s,1H),8.19(d,J=8.5Hz,1H),7.86(d,J=8.1Hz,1H),7.80–7.73(m,2H),7.73–7.68(m,1H),7.63(s,1H),7.60–7.51(m,2H),5.33(s,2H);Tested: 1 H NMR (400MHz, CDCl 3 ): δ8.52(d, J=8.0Hz, 1H), 8.28(s, 1H), 8.19(d, J=8.5Hz, 1H), 7.86(d, J=8.1Hz,1H),7.80–7.73(m,2H),7.73–7.68(m,1H),7.63(s,1H),7.60–7.51(m,2H),5.33(s,2H);
13C NMR(100MHz,CDCl3):δ161.0,153.6,148.8,140.0,137.5,132.4,130.7,130.2,129.4,128.8,128.0(2C),127.5(2C),127.3(2C),126.1,101.1,49.4ppm; 13 C NMR (100MHz, CDCl 3 ): δ161.0, 153.6, 148.8, 140.0, 137.5, 132.4, 130.7, 130.2, 129.4, 128.8, 128.0(2C), 127.5(2C), 127.3(2C), 126.1, 101.1, 49.4 ppm;
HRMS(m/z):Exact mass calcd for C19H12N2O[M]+:284.0950;found 284.0947。HRMS (m/z): Exact mass calcd for C 19 H 12 N 2 O [M] + : 284.0950; found 284.0947.
实施例2:及喜树碱的制备Example 2: and camptothecin preparation of
1)取化合物6(8.5g,73mmol)于500mL圆底烧瓶中,加入140mL(0.5M)的干燥四氢呋喃,于-78℃下滴加65mL二异丙基氨基锂(2.5N),-78℃下反应15分钟,使体系升温至20℃并反应15分钟,迅速加入23.2mL三甲基氯硅烷,于20℃下反应15分钟,加入饱和碳酸氢钠,用二氯甲烷萃取,合并萃取液,用饱和碳酸氢钠洗涤,无水硫酸钠干燥,过滤,旋干溶剂,柱层析(3%乙酸乙酯/石油醚),得淡黄色液体(3.3g,产率为89%),Rf=0.56(20%乙酸乙酯-石油醚);1) Take compound 6 (8.5g, 73mmol) in a 500mL round bottom flask, add 140mL (0.5M) of dry tetrahydrofuran, add 65mL lithium diisopropylamide (2.5N) dropwise at -78°C, React at low temperature for 15 minutes, raise the temperature of the system to 20°C and react for 15 minutes, quickly add 23.2mL trimethylchlorosilane, react at 20°C for 15 minutes, add saturated sodium bicarbonate, extract with dichloromethane, combine the extracts, Washed with saturated sodium bicarbonate, dried over anhydrous sodium sulfate, filtered, spin-dried the solvent, and column chromatography (3% ethyl acetate/petroleum ether) gave a light yellow liquid (3.3g, yield 89%), Rf= 0.56 (20% ethyl acetate-petroleum ether);
取原甲酸三乙酯(12.7mL,77mmol)于500mL圆底烧瓶中,加入130mL(0.5M)的干燥二氯甲烷,于-78℃下滴加9mL四氯化锡,于-78℃下反应15分钟,加入上一步所得的粗品,于-78℃下反应1小时,加入饱和碳酸氢钠淬灭反应,硅藻土过滤,二氯甲烷萃取,合并萃取液,用饱和碳酸氢钠洗涤,无水硫酸钠干燥,过滤,旋干溶剂,柱层析(5-20%乙酸乙酯/石油醚),得淡黄色液体,即:化合物7(4.9g,两步产率为39%),Rf=0.38(10%乙酸乙酯-石油醚)。Take triethyl orthoformate (12.7mL, 77mmol) in a 500mL round bottom flask, add 130mL (0.5M) of dry dichloromethane, add 9mL of tin tetrachloride dropwise at -78°C, and react at -78°C For 15 minutes, add the crude product obtained in the previous step, react at -78°C for 1 hour, add saturated sodium bicarbonate to quench the reaction, filter with diatomaceous earth, extract with dichloromethane, combine the extracts, wash with saturated sodium bicarbonate, no Dried over sodium sulfate, filtered, spin-dried the solvent, and column chromatography (5-20% ethyl acetate/petroleum ether) gave a light yellow liquid, namely: compound 7 (4.9g, two-step yield 39%), Rf =0.38 (10% ethyl acetate-petroleum ether).
2)取化合物7(3.6g,21mmol)于250mL圆底烧瓶中,加入100mL(0.5M)的干燥四氢呋喃,于-78℃下滴加10mL二异丙基氨基锂(2.5N),于-78℃下反应30分钟,加入2.3mL氰基甲酸乙酯,于-78℃下反应4小时,加入饱和氯化铵淬灭反应,用二氯甲烷萃取,合并萃取液,用饱和氯化钠洗涤,无水硫酸钠干燥,过滤,旋干溶剂;2) Take compound 7 (3.6g, 21mmol) in a 250mL round bottom flask, add 100mL (0.5M) of dry tetrahydrofuran, add 10mL lithium diisopropylamide (2.5N) dropwise at -78°C, and React at ℃ for 30 minutes, add 2.3mL ethyl cyanoformate, react at -78℃ for 4 hours, add saturated ammonium chloride to quench the reaction, extract with dichloromethane, combine the extracts, wash with saturated sodium chloride, Dry over anhydrous sodium sulfate, filter, and spin dry the solvent;
将所得粗品直接溶于20mL(1.0M)的干燥四氢呋喃,于-78℃下滴加26mL双三甲基硅基氨基钾(1.0N),于-78℃下反应30分钟,加入9.2g Comins试剂,于室温下反应3小时,加入饱和氯化铵和二氯甲烷,二氯甲烷萃取3次,有机相用饱和氯化钠洗1次,无水硫酸钠干燥,过滤,旋干溶剂,柱层析(2-4%乙酸乙酯/石油醚),得淡黄色液体,即:化合物8(5.8g,两步产率为73%),Rf=0.57(5%乙酸乙酯-石油醚)。Dissolve the obtained crude product directly in 20 mL (1.0 M) of dry tetrahydrofuran, add 26 mL of potassium bistrimethylsilylamide (1.0 N) dropwise at -78 °C, react at -78 °C for 30 minutes, and add 9.2 g of Comins reagent , reacted at room temperature for 3 hours, added saturated ammonium chloride and dichloromethane, extracted 3 times with dichloromethane, washed the organic phase once with saturated sodium chloride, dried over anhydrous sodium sulfate, filtered, spin-dried the solvent, and the column layer Analysis (2-4% ethyl acetate/petroleum ether) gave a light yellow liquid, namely: compound 8 (5.8 g, yield 73% in two steps), Rf=0.57 (5% ethyl acetate-petroleum ether).
3)称取化合物8(4.0g,10.6mmol)和实施例1中制得的化合物5(3.2g,11.2mmol)于250mL圆底烧瓶中,加入373mg二氯二三苯基膦钯、251mg三苯基膦、101mg碘化亚铜,在氮气保护下加入106mL(0.1M)除氧的甲苯和9mL三乙胺,于60℃下反应2小时,硅藻土过滤,旋干溶剂,柱层析(10-20%乙酸乙酯/石油醚),得淡黄色液体,即:反应所需的共轭烯炔酯(5.7g,产率为75%),Rf=0.46(20%乙酸乙酯-石油醚)。3) Weigh compound 8 (4.0g, 10.6mmol) and compound 5 (3.2g, 11.2mmol) prepared in Example 1 in a 250mL round bottom flask, add 373mg dichloroditriphenylphosphine palladium, 251mg triphenylphosphine palladium, Phenylphosphine, 101mg cuprous iodide, add 106mL (0.1M) deoxygenated toluene and 9mL triethylamine under the protection of nitrogen, react at 60°C for 2 hours, filter with diatomaceous earth, spin to dry the solvent, column chromatography (10-20% ethyl acetate/petroleum ether), to obtain a light yellow liquid, that is: the conjugated enynyl ester required for the reaction (5.7 g, 75% yield), Rf = 0.46 (20% ethyl acetate-petroleum ether).
4)称取制备的共轭烯炔酯(58mg,0.11mmol)于10mL反应管中,加入0.6mL(0.2M)的二氯甲烷,于0℃下滴加0.05mL三氟乙酸,于0℃下反应12小时,旋干溶剂,再用真空泵抽干即可,将所得粗品直接溶于1mL甲醇,加入氢氧化钾(12mg,0.22mmol),于40℃下反应8小时,加水,用二氯甲烷萃取,合并萃取液,无水硫酸钠干燥,过滤,旋干溶剂,柱层析(1%甲醇/二氯甲烷),得淡黄色固体,即为(30mg,产率为73%),Rf=0.34(5%甲醇/二氯甲烷)。4) Weigh the prepared conjugated enynyl ester (58mg, 0.11mmol) into a 10mL reaction tube, add 0.6mL (0.2M) of dichloromethane, dropwise add 0.05mL trifluoroacetic acid at 0°C, react at 0°C for 12 hours, spin dry the solvent, and use Vacuum pump is enough, the obtained crude product is directly dissolved in 1mL methanol, potassium hydroxide (12mg, 0.22mmol) is added, reacted at 40°C for 8 hours, water is added, extracted with dichloromethane, combined extracts, anhydrous sodium sulfate Drying, filtering, spin-drying solvent, column chromatography (1% methanol/dichloromethane), a light yellow solid was obtained, namely (30 mg, 73% yield), Rf = 0.34 (5% methanol/dichloromethane).
将所制备的用于喜树碱的制备,具体合成方法如下:the prepared for camptothecin The preparation, the specific synthesis method is as follows:
1)称取上述所得产品(126mg,0.35mmol)于25mL圆底烧瓶中,加入7mL(0.05M)的乙腈,分批加入92微升三氟甲磺酸,于室温下反应0.5小时,加入饱和碳酸氢钠淬灭反应,加水,用二氯甲烷萃取,合并萃取液,无水硫酸钠干燥,过滤,旋干溶剂,柱层析(1%甲醇/二氯甲烷),得淡黄色固体,即:化合物9(95mg,产率为86%),Rf=0.33(5%甲醇/二氯甲烷)。1) Weigh the product obtained above (126mg, 0.35mmol) in a 25mL round bottom flask, add 7mL (0.05M) of acetonitrile, add 92 microliters of trifluoromethanesulfonic acid in batches, react at room temperature for 0.5 hours, add saturated sodium bicarbonate to quench the reaction, Add water, extract with dichloromethane, combine the extracts, dry over anhydrous sodium sulfate, filter, spin to dry the solvent, and column chromatography (1% methanol/dichloromethane) to obtain a light yellow solid, namely: compound 9 (95 mg, produced The yield was 86%), Rf = 0.33 (5% methanol/dichloromethane).
2)所得的化合物9,通过两步已知的合成方法可以实现喜树碱的全合成。(S.P.Chavan,M.S.Venkatraman,ARKIVOC 2005,165.)。2) The obtained compound 9 can realize camptothecin by a two-step known synthetic method full synthesis. (SP Chavan, MS Venkatraman, ARKIVOC 2005, 165.).
经测试:1H NMR(500MHz,DMSO):δ8.69(s,1H),8.17(d,J=8.4Hz,1H),8.13(d,J=8.1Hz,1H),7.87(t,J=7.5Hz,1H),7.72(t,J=7.4Hz,1H),7.35(s,1H),6.53(s,1H),5.43(s,2H),5.29(s,2H),1.95–1.76(m,2H),0.89(t,J=7.3Hz,3H);Tested: 1 H NMR (500MHz, DMSO): δ8.69(s, 1H), 8.17(d, J=8.4Hz, 1H), 8.13(d, J=8.1Hz, 1H), 7.87(t, J =7.5Hz,1H),7.72(t,J=7.4Hz,1H),7.35(s,1H),6.53(s,1H),5.43(s,2H),5.29(s,2H),1.95–1.76 (m,2H),0.89(t,J=7.3Hz,3H);
13C NMR(125MHz,DMSO):δ172.9,157.3,153.1,150.5,148.4,146.0,132.0,130.9,130.3,129.5,129.0,128.4,128.1,119.6,97.2,72.9,65.7,50.7,30.8,8.2ppm; 13 C NMR (125MHz, DMSO): δ172.9, 157.3, 153.1, 150.5, 148.4, 146.0, 132.0, 130.9, 130.3, 129.5, 129.0, 128.4, 128.1, 119.6, 97.2, 72.9, 65.7, 50.7, 320.8mpp;
HRMS(m/z):Exact mass calcd for C20H16N2O4[M]+:348.1110;found 348.1115。HRMS (m/z): Exact mass calcd for C 20 H 16 N 2 O 4 [M] + : 348.1110; found 348.1115.
实施例3:的制备Example 3: preparation of
1)称取化合物10(1.0g,4.1mmol)于250mL圆底烧瓶中,加入20mL乙腈、82mL硝酸银水溶液(0.1N)、20mL 10%氢氧化钠水溶液,于室温下反应15小时,硅藻土过滤,加入6N氢氧化钠水溶液调节pH值小于5,用乙酸乙酯萃取,合并萃取液,用1N盐酸水溶液洗1次,无水硫酸钠干燥,过滤,旋干溶剂;1) Weigh compound 10 (1.0g, 4.1mmol) in a 250mL round bottom flask, add 20mL acetonitrile, 82mL silver nitrate aqueous solution (0.1N), 20mL 10% sodium hydroxide aqueous solution, react at room temperature for 15 hours, diatoms Filter with soil, add 6N aqueous sodium hydroxide solution to adjust the pH value to less than 5, extract with ethyl acetate, combine the extracts, wash once with 1N aqueous hydrochloric acid solution, dry over anhydrous sodium sulfate, filter, and spin to dry the solvent;
将所得粗品直接溶于20mL(0.2M)N,N-二甲基甲酰胺,加入338mg碳酸钾、0.5mL硫酸二甲酯,于室温下反应2小时,加入甲醇淬灭反应,用乙酸乙酯萃取,合并萃取液,用饱和氯化钠洗涤,无水硫酸钠干燥,过滤,旋干溶剂,柱层析(15%乙酸乙酯/石油醚),得淡黄色液体,即:化合物11(1.06g,两步产率为99%),Rf=0.30(20%乙酸乙酯-石油醚)。Dissolve the obtained crude product directly in 20 mL (0.2M) N,N-dimethylformamide, add 338 mg potassium carbonate and 0.5 mL dimethyl sulfate, react at room temperature for 2 hours, add methanol to quench the reaction, and use ethyl acetate Extraction, combined extracts, washed with saturated sodium chloride, dried over anhydrous sodium sulfate, filtered, spin-dried solvent, column chromatography (15% ethyl acetate/petroleum ether), to obtain a light yellow liquid, namely: compound 11 (1.06 g, two-step yield 99%), Rf = 0.30 (20% ethyl acetate-petroleum ether).
2)称取化合物11(107mg,0.39mmol)和实施例1制备的化合物5(100mg,0.35mmol)于25mL圆底烧瓶中,加入14mg二氯二苯腈钯、20mg四氟硼酸三叔丁基膦、3mg碘化亚铜、392mg四丁基碘化铵,在氮气保护下加入3.5mL(0.1M)除氧的三乙胺/乙腈(1/4),于80℃下反应2小时,硅藻土过滤,旋干溶剂,柱层析(10-20%乙酸乙酯/石油醚),得淡黄色固体,即:反应所需的共轭烯炔酯(65mg,产率为38%),Rf=0.30(40%乙酸乙酯-石油醚)。2) Weigh compound 11 (107mg, 0.39mmol) and compound 5 (100mg, 0.35mmol) prepared in Example 1 in a 25mL round bottom flask, add 14mg dichlorodibenzonitrile palladium, 20mg tri-tert-butyl tetrafluoroborate Phosphine, 3mg cuprous iodide, 392mg tetrabutylammonium iodide, add 3.5mL (0.1M) deoxygenated triethylamine/acetonitrile (1/4) under nitrogen protection, react at 80°C for 2 hours, silicon Filter through algal earth, spin to dry the solvent, and column chromatography (10-20% ethyl acetate/petroleum ether) to obtain a light yellow solid, namely: the conjugated enynyl ester required for the reaction (65 mg, 38% yield), Rf = 0.30 (40% ethyl acetate-petroleum ether).
3)称取制备的共轭烯炔酯(47mg,0.1mmol)于5mL反应瓶中,加入0.6mL(0.2M)的二氯甲烷,于0℃下滴加0.05mL三氟乙酸,于0℃下反应12小时,旋干溶剂,再用真空泵抽干即可,将所得粗品直接溶于1mL甲醇,加入碳酸铯(65mg,0.2mmol),于40℃下反应12小时,加水,用二氯甲烷萃取,合并萃取液,无水硫酸钠干燥,过滤,旋干溶剂,柱层析(5-10%甲醇/二氯甲烷),得淡黄色固体,即为(19.2mg,两步产率为56%),Rf=0.51(5%甲醇-二氯甲烷)。3) Weigh the prepared conjugated enynyl ester (47mg, 0.1mmol) into a 5mL reaction flask, add 0.6mL (0.2M) of dichloromethane, dropwise add 0.05mL trifluoroacetic acid at 0°C, react at 0°C for 12 hours, spin dry the solvent, and use Vacuum pump is enough, the resulting crude product is directly dissolved in 1mL of methanol, cesium carbonate (65mg, 0.2mmol) is added, reacted at 40°C for 12 hours, added water, extracted with dichloromethane, combined extracts, dried over anhydrous sodium sulfate , filtered, spin-dried the solvent, and column chromatography (5-10% methanol/dichloromethane) gave a light yellow solid, namely (19.2 mg, 56% yield over two steps), Rf = 0.51 (5% methanol-dichloromethane).
经测试:1H NMR(500MHz,CDCl3):δ8.23(s,1H),8.17(d,J=8.5Hz,1H),7.89–7.81(m,2H),7.79–7.74(m,1H),7.61–7.55(m,1H),7.54(s,1H),7.06(s,1H),5.31(s,2H),4.04(s,3H),4.03(s,3H);Tested: 1 H NMR (500MHz, CDCl 3 ): δ8.23(s, 1H), 8.17(d, J=8.5Hz, 1H), 7.89–7.81(m, 2H), 7.79–7.74(m, 1H ),7.61–7.55(m,1H),7.54(s,1H),7.06(s,1H),5.31(s,2H),4.04(s,3H),4.03(s,3H);
13C NMR(125MHz,CDCl3):δ160.3,153.8,153.4,149.8,148.7,138.7,132.9,130.5,130.1,129.3,128.8,128.0,127.8,127.1,120.3,107.2,107.2,100.8,56.3,56.1,49.5ppm; 13 C NMR (125MHz, CDCl 3 ): δ160.3, 153.8, 153.4, 149.8, 148.7, 138.7, 132.9, 130.5, 130.1, 129.3, 128.8, 128.0, 127.8, 127.1, 120.3, 107.2, 107.565.2, 100.3, 8 49.5ppm;
HRMS(m/z):Exact mass calcd for C21H16N2O3[M]+:344.1161;found 344.1163。HRMS (m/z): Exact mass calcd for C 21 H 16 N 2 O 3 [M]+: 344.1161; found 344.1163.
实施例4:的制备Example 4: preparation of
1)取化合物12(1.0g,7.0mmol)溶于35mL(0.2M)的干燥四氢呋喃,于-78℃下加入9.1mL双(三甲基硅基)氨基钾,反应30分钟,加入3.0g N-苯基双(三氟甲烷磺酸亚胺),于室温下反应过夜,加入饱和氯化铵淬灭反应,加水,用乙酸乙酯萃取,合并萃取液,用饱和氯化钠洗涤,无水硫酸钠干燥,过滤,旋干溶剂,柱层析(5%乙酸乙酯/石油醚),得淡黄色固体,即:化合物13(1.93g,产率为100%),Rf=0.66(20%乙酸乙酯-石油醚)。1) Dissolve compound 12 (1.0 g, 7.0 mmol) in 35 mL (0.2 M) of dry tetrahydrofuran, add 9.1 mL of bis(trimethylsilyl) potassium amide at -78°C, react for 30 minutes, add 3.0 g of N -Phenyl bis(imine trifluoromethanesulfonate), react overnight at room temperature, add saturated ammonium chloride to quench the reaction, add water, extract with ethyl acetate, combine the extracts, wash with saturated sodium chloride, anhydrous Sodium sulfate was dried, filtered, the solvent was spin-dried, and column chromatography (5% ethyl acetate/petroleum ether) gave a light yellow solid, namely: compound 13 (1.93 g, yield 100%), Rf=0.66 (20% ethyl acetate-petroleum ether).
2)称取化合物13(97mg,0.35mmol)和实施例1制备的化合物5(100mg,0.35mmol)于25mL圆底烧瓶中,加入20mg四三苯基膦钯、392mg四丁基碘化铵、3.4mg碘化亚铜,在氮气保护下加入3.5mL(0.1M)除氧的三乙胺/乙腈(1/4),于80℃下反应4小时,硅藻土过滤,旋干溶剂,柱层析(10-20%乙酸乙酯/石油醚),得淡黄色固体,即:反应所需的共轭烯炔酯(106mg,产率为94%),Rf=0.44(30%乙酸乙酯-石油醚)。2) Weigh compound 13 (97mg, 0.35mmol) and compound 5 (100mg, 0.35mmol) prepared in Example 1 in a 25mL round bottom flask, add 20mg tetraphenylphosphine palladium, 392mg tetrabutylammonium iodide, Add 3.4mg of cuprous iodide to 3.5mL (0.1M) deoxygenated triethylamine/acetonitrile (1/4) under nitrogen protection, react at 80°C for 4 hours, filter with diatomaceous earth, spin dry the solvent, and Chromatography (10-20% ethyl acetate/petroleum ether) yielded a pale yellow solid, namely: the conjugated enynyl ester required for the reaction (106 mg, 94% yield), Rf = 0.44 (30% ethyl acetate-petroleum ether).
3)称取制备的共轭烯炔酯(50mg,0.12mmol)于5mL反应瓶中,加入0.6mL(0.2M)的二氯甲烷,于0℃下滴加0.05mL三氟乙酸,于0℃下反应12小时,旋干溶剂,再用真空泵抽干即可,将所得粗品直接溶于1mL甲醇,加入叔丁醇钾(27mg,0.24mmol),于室温下反应5小时,加水,用二氯甲烷萃取,合并萃取液,无水硫酸钠干燥,过滤,旋干溶剂,柱层析(50-80%乙酸乙酯/二氯甲烷),得淡黄色固体,即为(32mg,两步产率为95%),Rf=0.43(5%甲醇-二氯甲烷)。3) Weigh the prepared conjugated enynyl ester (50mg, 0.12mmol) into a 5mL reaction flask, add 0.6mL (0.2M) of dichloromethane, dropwise add 0.05mL trifluoroacetic acid at 0°C, react at 0°C for 12 hours, spin dry the solvent, and use Vacuum pump to dry, the resulting crude product was directly dissolved in 1mL of methanol, potassium tert-butoxide (27mg, 0.24mmol) was added, reacted at room temperature for 5 hours, added water, extracted with dichloromethane, combined extracts, anhydrous sodium sulfate Drying, filtering, spin-drying solvent, column chromatography (50-80% ethyl acetate/dichloromethane), to obtain a light yellow solid, which is (32 mg, 95% yield over two steps), Rf = 0.43 (5% methanol-dichloromethane).
经测试:1H NMR(300MHz,CDCl3):δ8.29(s,1H),8.17(d,J=8.5Hz,1H),7.88(d,J=8.1Hz,1H),7.77(t,J=7.7Hz,1H),7.60(t,J=7.5Hz,1H),7.28(s,1H),5.23(s,2H),2.98(dd,J=17.3,8.1Hz,4H),2.36–2.06(m,2H);Tested: 1 H NMR (300MHz, CDCl 3 ): δ8.29(s, 1H), 8.17(d, J=8.5Hz, 1H), 7.88(d, J=8.1Hz, 1H), 7.77(t, J=7.7Hz, 1H), 7.60(t, J=7.5Hz, 1H), 7.28(s, 1H), 5.23(s, 2H), 2.98(dd, J=17.3, 8.1Hz, 4H), 2.36– 2.06(m,2H);
13C NMR(125MHz,CDCl3):δ159.6,156.2,153.2,148.7,144.7,133.5,130.8,130.2,129.4,129.1,128.0,127.8,127.3,99.4,49.5,34.2,29.9,23.9ppm; 13 C NMR (125MHz, CDCl 3 ): δ159.6, 156.2, 153.2, 148.7, 144.7, 133.5, 130.8, 130.2, 129.4, 129.1, 128.0, 127.8, 127.3, 99.4, 49.5, 34.2, 29.9, 23.9ppm;
HRMS(m/z):Exact mass calcd for C18H14N2O[M]+:274.1106;found 274.1107。HRMS (m/z): Exact mass calcd for C 18 H 14 N 2 O [M] + : 274.1106; found 274.1107.
实施例5:的制备Example 5: preparation of
1)称取化合物14(750mg,3.5mmol)和实施例1制备的化合物5(500mg,1.8mmol)于50mL圆底烧瓶中,加入100mg四三苯基膦钯、2.0g四丁基碘化铵、17mg碘化亚铜,在氮气保护下加入18mL(0.1M)除氧的三乙胺/乙腈(1/4),于50℃下反应4小时,硅藻土过滤,旋干溶剂,柱层析(30%乙酸乙酯/石油醚),得淡黄色固体,即:反应所需的共轭烯炔酯(628mg,产率为97%),Rf=0.52(50%乙酸乙酯-石油醚)。1) Weigh compound 14 (750mg, 3.5mmol) and compound 5 (500mg, 1.8mmol) prepared in Example 1 in a 50mL round bottom flask, add 100mg tetraphenylphosphine palladium, 2.0g tetrabutylammonium iodide , 17mg cuprous iodide, under the protection of nitrogen, add 18mL (0.1M) deoxygenated triethylamine/acetonitrile (1/4), react at 50°C for 4 hours, filter with diatomaceous earth, spin to dry the solvent, column layer Analysis (30% ethyl acetate/petroleum ether) to give a light yellow solid, namely: the conjugated enynyl ester required for the reaction (628 mg, 97% yield), Rf = 0.52 (50% ethyl acetate-petroleum ether).
2)称取制备的共轭烯炔酯(200mg,0.55mmol)于10mL反应瓶中,加入2.7mL(0.2M)的二氯甲烷,于0℃下滴加0.2mL三氟乙酸,于0℃下反应12小时,旋干溶剂,再用真空泵抽干即可,将所得粗品直接溶于4mL甲醇,加入碳酸钾(150mg,1.1mmol),于室温下反应12小时,加水,用二氯甲烷萃取,合并萃取液,无水硫酸钠干燥,过滤,旋干溶剂,柱层析(2-2%甲醇/二氯甲烷),得淡褐色固体,即为(39mg,两步产率为30%),Rf=0.44(5%甲醇-二氯甲烷)。2) Weigh the prepared conjugated enynyl ester (200mg, 0.55mmol) into a 10mL reaction flask, add 2.7mL (0.2M) of dichloromethane, dropwise add 0.2mL trifluoroacetic acid at 0°C, react at 0°C for 12 hours, spin dry the solvent, and use The resulting crude product was directly dissolved in 4 mL of methanol, potassium carbonate (150 mg, 1.1 mmol) was added, and reacted at room temperature for 12 hours, water was added, extracted with dichloromethane, the extracts were combined, and dried over anhydrous sodium sulfate. Filtration, spin-dried solvent, column chromatography (2-2% methanol/dichloromethane), to obtain light brown solid, which is (39 mg, 30% yield over two steps), Rf = 0.44 (5% methanol-dichloromethane).
所得的化合物与公开文献(T.Kametani,H.Nemoto,H.Takeda,S.Takano,Tetrahedron 1970,26,5753;H.B.Zhou,G.S.Liu,Z.J.Yao,Org.Lett.2007,9,2003.)中已知化合物数据一致。The resulting compound Consistent with known compound data in published literature (T.Kametani, H.Nemoto, H.Takeda, S.Takano, Tetrahedron 1970, 26, 5753; HB Zhou, GS Liu, ZJ Yao, Org. Lett. 2007, 9, 2003.) .
实施例6:的制备Embodiment 6: preparation of
1)参照实施例1制备化合物5的方法,以化合物15为原料制备化合物16。1) Referring to the method for preparing compound 5 in Example 1, compound 16 was prepared using compound 15 as a raw material.
2)称取化合物16(100mg,0.36mmol)和已知化合物17(137mg,0.44mmol)于10mL圆底烧瓶中,加入14mg二氯二苯腈钯、20mg四氟硼酸三叔丁基膦、3mg碘化亚铜、400mg四丁基碘化铵,在氮气保护下加入3.6mL(0.1M)除氧的三乙胺/乙腈(1/4),于80℃下反应12小时,硅藻土过滤,旋干溶剂,柱层析(12-15%乙酸乙酯/石油醚),得淡黄色液体,即:反应所需的共轭烯炔酯(99mg,产率为62%),Rf=0.31(20%乙酸乙酯-石油醚)。2) Weigh compound 16 (100mg, 0.36mmol) and known compound 17 (137mg, 0.44mmol) into a 10mL round bottom flask, add 14mg dichlorodibenzonitrile palladium, 20mg tri-tert-butylphosphine tetrafluoroborate, 3mg Cuprous iodide, 400mg tetrabutylammonium iodide, add 3.6mL (0.1M) deoxygenated triethylamine/acetonitrile (1/4) under nitrogen protection, react at 80°C for 12 hours, filter with diatomaceous earth , spin to dry the solvent, column chromatography (12-15% ethyl acetate/petroleum ether), to obtain a light yellow liquid, that is: the conjugated enynyl ester required for the reaction (99 mg, 62% yield), Rf = 0.31 (20% ethyl acetate-petroleum ether).
3)称取制备的共轭烯炔酯(64mg,0.15mmol)于5mL反应瓶中,加入0.7mL(0.2M)的二氯甲烷,于0℃下滴加0.1mL三氟乙酸,于0℃下反应12小时,旋干溶剂,再用真空泵抽干即可,将所得粗品直接溶于1.5mL甲醇,加入三乙胺(42μL,0.3mmol),于室温下反应8小时,加水,用二氯甲烷萃取,合并萃取液,无水硫酸钠干燥,过滤,旋干溶剂,柱层析(20-30%乙酸乙酯/二氯甲烷),得淡黄色固体,即为(38mg,两步产率为74%),Rf=0.26(40%乙酸乙酯-石油醚)。3) Weigh the prepared conjugated enynyl ester (64mg, 0.15mmol) into a 5mL reaction flask, add 0.7mL (0.2M) of dichloromethane, dropwise add 0.1mL trifluoroacetic acid at 0°C, react at 0°C for 12 hours, spin dry the solvent, and use Vacuum pump to dry, the resulting crude product was directly dissolved in 1.5mL methanol, triethylamine (42μL, 0.3mmol) was added, reacted at room temperature for 8 hours, added water, extracted with dichloromethane, combined extracts, anhydrous sodium sulfate Dry, filter, spin dry the solvent, column chromatography (20-30% ethyl acetate/dichloromethane), obtain light yellow solid, namely (38 mg, 74% yield in two steps), Rf = 0.26 (40% ethyl acetate-petroleum ether).
经测试:1H NMR(500MHz,5%CD3OD/CDCl3):δ7.82(d,J=2.6Hz,1H),7.53(d,J=8.7Hz,1H),7.26(s,1H),7.13(s,1H),6.96(s,1H),6.85(s,1H),6.04(s,2H),5.05(s,3H);Tested: 1 H NMR (500MHz, 5% CD 3 OD/CDCl 3 ): δ7.82(d, J=2.6Hz, 1H), 7.53(d, J=8.7Hz, 1H), 7.26(s, 1H ),7.13(s,1H),6.96(s,1H),6.85(s,1H),6.04(s,2H),5.05(s,3H);
13C NMR(125MHz,5%CD3OD/CDCl3):δ160.9,158.1,149.7,148.5,140.3,132.3,131.5,127.8,127.6,124.8,123.1,106.9,103.7,101.9,100.6,97.0,55.6,51.9ppm; 13 C NMR (125MHz, 5% CD 3 OD/CDCl 3 ): δ160.9, 158.1, 149.7, 148.5, 140.3, 132.3, 131.5, 127.8, 127.6, 124.8, 123.1, 106.9, 103.7, 101.9, 100.6, 97.0, 55. 51.9ppm;
HRMS(m/z):Exact mass calcd for C18H13NO4[M]+:307.0845;found 307.0848。HRMS (m/z): Exact mass calcd for C 18 H 13 NO 4 [M]+: 307.0845; found 307.0848.
最后需要在此指出的是:以上仅是本发明的部分优选实施例,不能理解为对本发明保护范围的限制,本领域的技术人员根据本发明的上述内容做出的一些非本质的改进和调整均属于本发明的保护范围。Finally, it should be pointed out here that: the above are only some preferred embodiments of the present invention, and should not be interpreted as limiting the protection scope of the present invention. Those skilled in the art can make some non-essential improvements and adjustments based on the above-mentioned contents of the present invention. All belong to the protection scope of the present invention.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610296979.0A CN105859716B (en) | 2016-05-06 | 2016-05-06 | In a kind of synthesis camptothecine compounds 56 and ring structure method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610296979.0A CN105859716B (en) | 2016-05-06 | 2016-05-06 | In a kind of synthesis camptothecine compounds 56 and ring structure method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105859716A true CN105859716A (en) | 2016-08-17 |
CN105859716B CN105859716B (en) | 2018-03-09 |
Family
ID=56630450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610296979.0A Expired - Fee Related CN105859716B (en) | 2016-05-06 | 2016-05-06 | In a kind of synthesis camptothecine compounds 56 and ring structure method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105859716B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1096297A (en) * | 1992-09-08 | 1994-12-14 | 史密丝克莱恩比彻姆公司 | The method of synthetic camptothecine and Mai Pi star and their analogue and allied compound |
CN101337928A (en) * | 2008-08-27 | 2009-01-07 | 中国科学院上海有机化学研究所 | Quinoline compounds, synthetic methods and their application in the synthesis of camptothecin alkaloids |
CN103923006A (en) * | 2014-04-30 | 2014-07-16 | 华东理工大学 | Method of constructing isoquinolinone framework and synthesis of alkaloid 8-oxypseudopalmatine |
-
2016
- 2016-05-06 CN CN201610296979.0A patent/CN105859716B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1096297A (en) * | 1992-09-08 | 1994-12-14 | 史密丝克莱恩比彻姆公司 | The method of synthetic camptothecine and Mai Pi star and their analogue and allied compound |
CN101337928A (en) * | 2008-08-27 | 2009-01-07 | 中国科学院上海有机化学研究所 | Quinoline compounds, synthetic methods and their application in the synthesis of camptothecin alkaloids |
CN103923006A (en) * | 2014-04-30 | 2014-07-16 | 华东理工大学 | Method of constructing isoquinolinone framework and synthesis of alkaloid 8-oxypseudopalmatine |
Also Published As
Publication number | Publication date |
---|---|
CN105859716B (en) | 2018-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7323603B2 (en) | Tricyclic Fused Furan-Substituted Piperidinedione Compounds | |
CN106496222A (en) | A kind of imidazo [1,2 a] pyridine compounds and its preparation method and application | |
CN110551145A (en) | furocoumarin-Tr gers' Base derivatives, and synthetic method and application thereof | |
CN106977415A (en) | One planting sand storehouse must be bent intermediate and preparation method thereof | |
CN105622709A (en) | Tanshinone I derivative, preparation method and applications thereof | |
CN105801573B (en) | It is a kind of to synthesize jamaicin category and in ebony wood category natural products 66 and the method for ring structure | |
CN113105468B (en) | Polycyclic spiroindolone compound containing benzopyrone and preparation method and application thereof | |
CN103304478B (en) | Alkaloidal intermediate of one class synthesis renieramycins type and preparation method thereof | |
CN105859716B (en) | In a kind of synthesis camptothecine compounds 56 and ring structure method | |
WO2009074020A9 (en) | Alpha-amino-n-substituted amides, pharmaceutical composition containing them and uses thereof | |
CN110143934B (en) | Fluorine-containing taxane compound and preparation method and application thereof | |
CN103709101B (en) | Synthetic intermediate of one class renieramycin G and preparation method thereof | |
CN104583203B (en) | SCHWEINFURTHIN analogs | |
CN102321084A (en) | Method for synthesizing benzo[c]pyridine[4,3,2-mn]acridine-8-one | |
KR100921036B1 (en) | Method of preparing taxane derivatives and intermediates used therein | |
CN110317169A (en) | A kind of 1- substituted isoquinoline ketone compound and preparation method thereof | |
CN111793017B (en) | Preparation method of lactam compound | |
CN103408559B (en) | A kind of fast synthesis method of camptothecin analogues | |
CN109912640B (en) | Preparation method of 2-pyrrolidone compound | |
CN102952067A (en) | Pyridoxal derivative for pegylation modification of N terminal of protein and preparation method and application thereof | |
CN107445914B (en) | A kind of 2,2,5-trisubstituted 1,3,4 oxadiazole derivative and its synthesis method | |
CN108610301B (en) | A class of chiral heteroaromatic amine derivatives and their synthetic methods and applications | |
CN106366069B (en) | A kind of preparation method of N- heteroaryl carbazole compound | |
CN104945298B (en) | Trifluoromethyl thioperoxide and preparation method thereof | |
CN105566347B (en) | A kind of method for preparing the nitrine indoline of loop coil 2 two |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180309 Termination date: 20200506 |
|
CF01 | Termination of patent right due to non-payment of annual fee |